FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1937764639> ?p ?o ?g. }

• W1937764639 endingPage "1457" @default.
• W1937764639 startingPage "1448" @default.
• W1937764639 abstract "PURPOSE Childrens Cancer Group (CCG) protocol 2861 was designed to test the feasibility of aggressively timed induction therapy followed by autologous or allogeneic bone marrow transplantation (BMT) as the sole postremission therapy for newly diagnosed children with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). PATIENTS AND METHODS Between April 1988 and October 1989, 142 patients were eligible for study. All patients entered received a timing-intensive five-drug induction of dexamethasone, cytarabine (Ara-C), thioguanine, etoposide, and daunorubicin (DCTER) over 4 days with a second cycle administered after 6 days of rest, irrespective of hematologic status at that time. Most patients subsequently received a second two-cycle induction course. Those who achieved remission were eligible for bone marrow ablative therapy with busulfan and cyclophosphamide, followed by 4-hydroperoxy-cyclophosphamide (4-HC)-purged autologous or allogeneic BMT rescue. RESULTS One hundred eight (76%) patients achieved remission: 19 (13%) died of complications of the leukemia and/or chemotherapy, and 15 (11%) failed to achieve remission. Seventy-four patients subsequently underwent BMT with either autologous (n = 58) or allogeneic (n = 16) rescue. For patients who received autologous rescue with 4-HC-purged grafts, the actuarial disease-free survival (DFS) rate at 3 years from the day of transplant is 51%, compared with 55% for patients who received allogeneic grafts (P = .92). At 3 years, the overall actuarial survival rate for all 142 patients entered on this study is 45%, with an event-free survival (EFS) rate of 37%. Adverse prognostic factors for outcome included an elevated WBC count or the presence of CNS leukemia at the time of AML diagnosis. CONCLUSION Results suggest that aggressively timed induction therapy followed by marrow ablation and BMT rescue with either autologous or allogeneic grafts for children with newly diagnosed AML or MDS is both feasible and effective." @default.
• W1937764639 created "2016-06-24" @default.
• W1937764639 creator A5000374788 @default.
• W1937764639 creator A5000624483 @default.
• W1937764639 creator A5006221398 @default.
• W1937764639 creator A5006788534 @default.
• W1937764639 creator A5007262193 @default.
• W1937764639 creator A5025630600 @default.
• W1937764639 creator A5026088642 @default.
• W1937764639 creator A5031499863 @default.
• W1937764639 creator A5060477535 @default.
• W1937764639 creator A5071035695 @default.
• W1937764639 date "1993-08-01" @default.
• W1937764639 modified "2023-09-27" @default.
• W1937764639 title "Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study." @default.
• W1937764639 cites W1529957398 @default.
• W1937764639 cites W1533557093 @default.
• W1937764639 cites W1545357460 @default.
• W1937764639 cites W186484676 @default.
• W1937764639 cites W1907798206 @default.
• W1937764639 cites W1912991550 @default.
• W1937764639 cites W1933741784 @default.
• W1937764639 cites W1942780970 @default.
• W1937764639 cites W1971387320 @default.
• W1937764639 cites W1974801185 @default.
• W1937764639 cites W1977797185 @default.
• W1937764639 cites W2011474926 @default.
• W1937764639 cites W2023023793 @default.
• W1937764639 cites W2150113701 @default.
• W1937764639 cites W2266287318 @default.
• W1937764639 cites W2338217525 @default.
• W1937764639 cites W2339392195 @default.
• W1937764639 cites W2409068986 @default.
• W1937764639 cites W2409081980 @default.
• W1937764639 cites W2412055789 @default.
• W1937764639 cites W40973501 @default.
• W1937764639 cites W187925606 @default.
• W1937764639 cites W1983392832 @default.
• W1937764639 doi "https://doi.org/10.1200/jco.1993.11.8.1448" @default.
• W1937764639 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8336184" @default.
• W1937764639 hasPublicationYear "1993" @default.
• W1937764639 type Work @default.
• W1937764639 sameAs 1937764639 @default.
• W1937764639 citedByCount "135" @default.
• W1937764639 countsByYear W19377646392012 @default.
• W1937764639 countsByYear W19377646392013 @default.
• W1937764639 countsByYear W19377646392014 @default.
• W1937764639 countsByYear W19377646392015 @default.
• W1937764639 countsByYear W19377646392016 @default.
• W1937764639 countsByYear W19377646392017 @default.
• W1937764639 crossrefType "journal-article" @default.
• W1937764639 hasAuthorship W1937764639A5000374788 @default.
• W1937764639 hasAuthorship W1937764639A5000624483 @default.
• W1937764639 hasAuthorship W1937764639A5006221398 @default.
• W1937764639 hasAuthorship W1937764639A5006788534 @default.
• W1937764639 hasAuthorship W1937764639A5007262193 @default.
• W1937764639 hasAuthorship W1937764639A5025630600 @default.
• W1937764639 hasAuthorship W1937764639A5026088642 @default.
• W1937764639 hasAuthorship W1937764639A5031499863 @default.
• W1937764639 hasAuthorship W1937764639A5060477535 @default.
• W1937764639 hasAuthorship W1937764639A5071035695 @default.
• W1937764639 hasConcept C126322002 @default.
• W1937764639 hasConcept C141071460 @default.
• W1937764639 hasConcept C143998085 @default.
• W1937764639 hasConcept C2776611710 @default.
• W1937764639 hasConcept C2776694085 @default.
• W1937764639 hasConcept C2776755627 @default.
• W1937764639 hasConcept C2778041864 @default.
• W1937764639 hasConcept C2778119113 @default.
• W1937764639 hasConcept C2778461978 @default.
• W1937764639 hasConcept C2778729363 @default.
• W1937764639 hasConcept C2778880498 @default.
• W1937764639 hasConcept C2780007613 @default.
• W1937764639 hasConcept C2780611847 @default.
• W1937764639 hasConcept C2911091166 @default.
• W1937764639 hasConcept C71924100 @default.
• W1937764639 hasConceptScore W1937764639C126322002 @default.
• W1937764639 hasConceptScore W1937764639C141071460 @default.
• W1937764639 hasConceptScore W1937764639C143998085 @default.
• W1937764639 hasConceptScore W1937764639C2776611710 @default.
• W1937764639 hasConceptScore W1937764639C2776694085 @default.
• W1937764639 hasConceptScore W1937764639C2776755627 @default.
• W1937764639 hasConceptScore W1937764639C2778041864 @default.
• W1937764639 hasConceptScore W1937764639C2778119113 @default.
• W1937764639 hasConceptScore W1937764639C2778461978 @default.
• W1937764639 hasConceptScore W1937764639C2778729363 @default.
• W1937764639 hasConceptScore W1937764639C2778880498 @default.
• W1937764639 hasConceptScore W1937764639C2780007613 @default.
• W1937764639 hasConceptScore W1937764639C2780611847 @default.
• W1937764639 hasConceptScore W1937764639C2911091166 @default.
• W1937764639 hasConceptScore W1937764639C71924100 @default.
• W1937764639 hasIssue "8" @default.
• W1937764639 hasLocation W19377646391 @default.
• W1937764639 hasLocation W19377646392 @default.
• W1937764639 hasOpenAccess W1937764639 @default.
• W1937764639 hasPrimaryLocation W19377646391 @default.
• W1937764639 hasRelatedWork W1964817778 @default.
• W1937764639 hasRelatedWork W2010948941 @default.

• next